Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-27 @ 7:09 AM
Study NCT ID:
NCT00362050
Status:
COMPLETED
Last Update Posted:
2007-08-29
First Post:
2006-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RBx11160 Phase II Dose Ranging Study RBx/MMV05-06
Sponsor:
Medicines for Malaria Venture
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RBx/MMV05-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None